Relationship between bullous pemphigoid and metabolic syndrome and its relevant traits: a bidirectional two-sample Mendelian randomization study
- PMID: 39760936
- DOI: 10.1007/s00403-024-03704-8
Relationship between bullous pemphigoid and metabolic syndrome and its relevant traits: a bidirectional two-sample Mendelian randomization study
Abstract
Bullous pemphigoid (BP) is a chronic autoimmune subepidermal blistering disease, affecting mostly the elderly. Metabolic syndrome (MetS) is a set of metabolic disorders including obesity, hypertension, glucose intolerance, and dyslipidemia. Observational studies have revealed a correlation between BP and MetS with controversial results and the causal relationship needs to be clarified. In the study of BP and MetS, observational investigations are prone to be biased by confounding factors such as the use of corticosteroids or age. However, Mendelian randomization (MR) is less susceptible to confounding factors and reverse causality. In this study, we aimed to use two-sample MR to investigate the causal correlation between BP and MetS from a genetic perspective. We used genome-wide association study (GWAS) data of BP, MetS, and its relevant traits to perform the analysis. The relevant traits consisted of four aspects, including central obesity, hypertension, impaired glucose tolerance, and dyslipidemia. In the results, it demonstrated no causal association of BP on the risk of MetS or its relevant traits and it revealed no significant linkage in the reverse procedure. This analysis enriched the research on the association of BP and MetS and provided evidence from a genetic perspective.
Keywords: Bullous pemphigoid; Causality; Genetic; Mendelian randomization; Metabolic syndrome.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics statement: The manuscript does not contain clinical studies or patient data, and ethical approval is not required. Competing interests: The authors declare no competing interests.
References
-
- Steele CE, Morrell D, Evans M (2019) Metabolic syndrome and inflammatory skin conditions. Curr Opin Pediatr 31:515–522. https://doi.org/10.1097/mop.0000000000000790 - DOI - PubMed
-
- Ünlü B, Türsen Ü (2018) Autoimmune skin diseases and the metabolic syndrome. Clin Dermatol 36:67–71. https://doi.org/10.1016/j.clindermatol.2017.09.012 - DOI - PubMed
-
- Lee S, Rastogi S, Hsu DY, Nardone B, Silverberg JI (2021) Association of bullous pemphigoid and comorbid health conditions: a case-control study. Arch Dermatol Res 313:327–332. https://doi.org/10.1007/s00403-020-02100-2 - DOI - PubMed
-
- Zhang B, Chen X, Liu Y, Chen F, Yang N, Li L (2022) Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China. Ther Adv Chronic Dis 13:20406223221130707. https://doi.org/10.1177/20406223221130707 - DOI - PubMed - PMC
-
- Nwankwo M, Okamkpa CJ, Danborno B (2022) Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: a case study from urban southeast Nigeria. Diabetes Metab Syndr 16:102665. https://doi.org/10.1016/j.dsx.2022.102665 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
